NCT07428707
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07428707
Title Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Heart, Lung, and Blood Institute (NHLBI)
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.